ArticleSurgical neurology international2026
Quality of life and functional outcomes in pediatric brain tumor survivors in resource-limited settings: A retrospective cohort study.
Article in Surgical neurology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pediatric brain tumors represent the leading cause of cancer-related mortality in children, with survival outcomes in low-middle-income countries (LMICs) significantly inferior to those in high-income countries. While survival data from LMICs are emerging, health-related quality of life (HRQOL) and functional outcomes remain poorly characterized. This study aimed to evaluate HRQOL and identify predictors of functional outcomes in pediatric brain tumor survivors at a tertiary care center in India. Methods: A retrospective cohort study was conducted on pediatric brain tumor patients (age 2-18 years) treated between January 2019 and December 2023 at our tertiary care center. For the present analysis, we included 92 children who were alive and in active follow-up for at least 12 months after completion of primary treatment and were therefore considered survivors. The Pediatric Quality of Life Inventory (PedsQL) Brain Tumor Module and Lansky Performance Scale were administered at the time of the last follow-up visit (minimum 12 months post-treatment). Clinical variables, including tumor histology, location, treatment modality, complications, and late effects, were extracted, and univariate and multivariate regression were used to identify predictors of HRQOL. Results: Among these 92 survivors, the mean follow-up duration was 32.4 months (range 12-58 months). In the initial cohort of 134 children, 58.7% were alive at last follow-up. Mean total PedsQL score was 64.3 ± 18.2. Cognitive functioning (56.8 ± 21.4) and procedural anxiety (58.2 ± 19.6) subscales scored lowest. Multivariate analysis revealed that supratentorial tumor location (β = -12.4, Conclusion: Pediatric brain tumor survivors in LMICs demonstrate impaired HRQOL, particularly in cognitive and emotional domains. Tumor location, treatment-related toxicity, and extent of resection significantly impact long-term outcomes. These findings emphasize the need for comprehensive survivorship programs and neurocognitive rehabilitation strategies in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.